CJC-1295 with Ipamorelin CJC-1295 is a growth hormone-releasing hormone (GHRH), while Ipamorelin is a growth hormone-releasing peptide (GHRP)
On Day 3 post-injury, GHK-AgNPs and GHK-Cu-AgNPs achieved the highest closure rates (32% and 31%, respectively) compared with GHK-Cu and the positive control (both 25%) and the negative control (22%)
48 weeks 6-8 x 10 mg vials Maintenance at 12 mg drives most of the total
But its also the stage that requires the most careful investigation, because removing the wrong things or missing the real triggers entirely means the subsequent steps are building on an unstable foundation
As these pathways are important for Mtb virulence and to prevent the buildup of potentially toxic metabolites, it is vital to Mtb that these pathways are rigorously regulated
For right now, however, this is the best weve got